首页 > 最新文献

TMR生命研究最新文献

英文 中文
Drug-related problems among type II diabetes mellitus patients with hypertension: a cross-sectional study 2型糖尿病合并高血压患者的药物相关问题:一项横断面研究
Pub Date : 2020-01-25 DOI: 10.12032/LIFE2020-0125-101
J. Nzayisenga, Nicholas Njau Ngomi, J. Nyiligira
Introduction: Patients with type II diabetes mellitus (T2DM) and hypertension (HTN) are at increased threat for long experiencing various problems related to medicine as they frequently received different medications for managing their condition. Recently, there were no studies done locally on drug-related problems (DRPs) among T2DM patients with HTN. Thus, this study aims to assess the DRPs among T2DM patients with HTN admitted at Kibuye Referral Hospital (KRH). DRPs were drug safety problems, drug effectiveness problems and other drug problems. Methods: A retrospective cross-sectional study involved patients' files with T2DM and HTN, who were admitted at KRH from January 2013 to December 2017. The identification and classification of DRPs were based on pharmaceutical care network Europe (PCNE) classification system version 8.02. A simple random sampling technique was used to choose study participants from the target population. Data that met inclusion and exclusion criteria were analyzed using STATA version 13. The Fisher exact test (bivariate analysis) and logistic regression (multivariate) were used to test association and p-value ≤ 0.05 was considered as statistically significant. An adjusted odd ratio (AOR) with a confidence interval (CI) of 95% was determined using binary logistic regression. Results: Findings revealed that the prevalence of DRPs was 81.29% (313/385) and most of them each patient had at least two DRPs (69.05%). The patients aged above 55 years old were more likely to develop DRPs than those with age below 35 years (AOR = 1.2; P = 0.02; 95% CI: 0.2–2.3). Nevertheless, there was no significant association between DRPs and middle age (between 35 and 54 age of old). The patients who consumed more than or equal to 5 drugs were 2.4 times more likely to develop DRPs than those who took the number of medicines less than 5 (AOR = 15.4; P < 0.001; 95% CI: 8.8–26.8). Also, traditional medicines use ((AOR = 1.9; P = 0.016; 95% CI: 1.1–3.5) and having drug-related complication (AOR = 2.4; P < 0.001; 95% CI: 1.9–3) had shown significant associations. The total causes of DRPs identified were 1626 and most causes of DRPs were arisen from drug use (45.01%) and prescribing (37.83%). The drug/ dose selections were the most frequent causes of DRPs (36.97%). Conclusion: Since the prevalence of DRPs were relatively high, various factors influencing DRPs were established and most causes of DRPs were arising from drug use & drug prescribing among T2DM patients with HTN. Early detection needed to enhance patient’s life quality. Conducting studies in other hospitals needed to establish the national planning of DRPs to eradicate DRPs among patients T2DM with HTN.
导论:2型糖尿病(T2DM)和高血压(HTN)患者长期经历各种药物相关问题的威胁增加,因为他们经常接受不同的药物来控制他们的病情。最近,国内没有关于T2DM合并HTN患者药物相关问题(DRPs)的研究。因此,本研究旨在评估Kibuye转诊医院(KRH)收治的T2DM合并HTN患者的DRPs。DRPs是药物安全问题、药物有效性问题和其他药物问题。方法:回顾性横断面研究纳入2013年1月至2017年12月在KRH住院的T2DM和HTN患者档案。drp的识别和分类基于欧洲药学服务网络(PCNE) 8.02版分类系统。采用简单的随机抽样技术从目标人群中选择研究参与者。符合纳入和排除标准的数据使用STATA version 13进行分析。采用Fisher精确检验(双变量分析)和logistic回归(多变量分析)检验相关性,以p值≤0.05为有统计学意义。采用二元逻辑回归确定校正奇数比(AOR),置信区间为95%。结果:调查结果显示,DRPs患病率为81.29%(313/385),其中大多数患者至少有2个DRPs(69.05%)。55岁以上的患者比35岁以下的患者更容易发生DRPs (AOR = 1.2;P = 0.02;95% ci: 0.2-2.3)。然而,DRPs与中年(35岁至54岁)之间没有显著关联。服用超过或等于5种药物的患者发生DRPs的可能性是服用药物少于5种的患者的2.4倍(AOR = 15.4;P < 0.001;95% ci: 8.8-26.8)。此外,传统药物使用(AOR = 1.9;P = 0.016;95% CI: 1.1-3.5)并有药物相关并发症(AOR = 2.4;P < 0.001;95% CI: 1.9-3)显示出显著的相关性。共发现DRPs原因1626例,其中用药(45.01%)和处方(37.83%)是导致DRPs的主要原因。药物/剂量选择是导致DRPs最常见的原因(36.97%)。结论:T2DM合并HTN患者DRPs患病率较高,影响DRPs的因素较多,DRPs的主要原因为用药和处方。早期发现有助于提高患者的生活质量。在其他医院开展研究需要建立全国性的drp计划,以根除T2DM合并HTN患者的drp。
{"title":"Drug-related problems among type II diabetes mellitus patients with hypertension: a cross-sectional study","authors":"J. Nzayisenga, Nicholas Njau Ngomi, J. Nyiligira","doi":"10.12032/LIFE2020-0125-101","DOIUrl":"https://doi.org/10.12032/LIFE2020-0125-101","url":null,"abstract":"Introduction: Patients with type II diabetes mellitus (T2DM) and hypertension (HTN) are at increased threat for long experiencing various problems related to medicine as they frequently received different medications for managing their condition. Recently, there were no studies done locally on drug-related problems (DRPs) among T2DM patients with HTN. Thus, this study aims to assess the DRPs among T2DM patients with HTN admitted at Kibuye Referral Hospital (KRH). DRPs were drug safety problems, drug effectiveness problems and other drug problems. Methods: A retrospective cross-sectional study involved patients' files with T2DM and HTN, who were admitted at KRH from January 2013 to December 2017. The identification and classification of DRPs were based on pharmaceutical care network Europe (PCNE) classification system version 8.02. A simple random sampling technique was used to choose study participants from the target population. Data that met inclusion and exclusion criteria were analyzed using STATA version 13. The Fisher exact test (bivariate analysis) and logistic regression (multivariate) were used to test association and p-value ≤ 0.05 was considered as statistically significant. An adjusted odd ratio (AOR) with a confidence interval (CI) of 95% was determined using binary logistic regression. Results: Findings revealed that the prevalence of DRPs was 81.29% (313/385) and most of them each patient had at least two DRPs (69.05%). The patients aged above 55 years old were more likely to develop DRPs than those with age below 35 years (AOR = 1.2; P = 0.02; 95% CI: 0.2–2.3). Nevertheless, there was no significant association between DRPs and middle age (between 35 and 54 age of old). The patients who consumed more than or equal to 5 drugs were 2.4 times more likely to develop DRPs than those who took the number of medicines less than 5 (AOR = 15.4; P < 0.001; 95% CI: 8.8–26.8). Also, traditional medicines use ((AOR = 1.9; P = 0.016; 95% CI: 1.1–3.5) and having drug-related complication (AOR = 2.4; P < 0.001; 95% CI: 1.9–3) had shown significant associations. The total causes of DRPs identified were 1626 and most causes of DRPs were arisen from drug use (45.01%) and prescribing (37.83%). The drug/ dose selections were the most frequent causes of DRPs (36.97%). Conclusion: Since the prevalence of DRPs were relatively high, various factors influencing DRPs were established and most causes of DRPs were arising from drug use & drug prescribing among T2DM patients with HTN. Early detection needed to enhance patient’s life quality. Conducting studies in other hospitals needed to establish the national planning of DRPs to eradicate DRPs among patients T2DM with HTN.","PeriodicalId":61869,"journal":{"name":"TMR生命研究","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43013276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A review of the treatment for insomnia in patients with cancers 癌症患者失眠治疗综述
Pub Date : 2020-01-25 DOI: 10.12032/LIFE2020-0125-301
Shuang Liu, Xiong-Zhi Wu
{"title":"A review of the treatment for insomnia in patients with cancers","authors":"Shuang Liu, Xiong-Zhi Wu","doi":"10.12032/LIFE2020-0125-301","DOIUrl":"https://doi.org/10.12032/LIFE2020-0125-301","url":null,"abstract":"","PeriodicalId":61869,"journal":{"name":"TMR生命研究","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41536227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A meta-analysis of the treatment of cancer-related insomnia with acupuncture 针灸治疗癌症相关性失眠的meta分析
Pub Date : 2020-01-25 DOI: 10.12032/LIFE2020-0125-102
Xuezhi Qi, M. Pan, T. Wen
{"title":"A meta-analysis of the treatment of cancer-related insomnia with acupuncture","authors":"Xuezhi Qi, M. Pan, T. Wen","doi":"10.12032/LIFE2020-0125-102","DOIUrl":"https://doi.org/10.12032/LIFE2020-0125-102","url":null,"abstract":"","PeriodicalId":61869,"journal":{"name":"TMR生命研究","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43359261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A review on the effects of sleep duration on hypertension 睡眠时间对高血压影响的研究进展
Pub Date : 2020-01-25 DOI: 10.12032/LIFE2020-0125-303
T. Adewunmi
{"title":"A review on the effects of sleep duration on hypertension","authors":"T. Adewunmi","doi":"10.12032/LIFE2020-0125-303","DOIUrl":"https://doi.org/10.12032/LIFE2020-0125-303","url":null,"abstract":"","PeriodicalId":61869,"journal":{"name":"TMR生命研究","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48486203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Assessment of quality of life in children with osteogenesis imperfecta: a review 成骨不全症儿童的生活质量评估:综述
Pub Date : 2020-01-01 DOI: 10.53388/life2020-0919-301
Yongjie Lai, Huijia Mao, Yueyang Zhang, Yibo Wu
{"title":"Assessment of quality of life in children with osteogenesis imperfecta: a review","authors":"Yongjie Lai, Huijia Mao, Yueyang Zhang, Yibo Wu","doi":"10.53388/life2020-0919-301","DOIUrl":"https://doi.org/10.53388/life2020-0919-301","url":null,"abstract":"","PeriodicalId":61869,"journal":{"name":"TMR生命研究","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70811857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress on the influence of opioids on fetal neurodevelopment during pregnancy 阿片类药物对妊娠期胎儿神经发育影响的研究进展
Pub Date : 2020-01-01 DOI: 10.53388/life2020-0424-301
Xialei Li, Yue-Han Guo, Shuting Wei, Ju Chen, Yibo Wu
{"title":"Research progress on the influence of opioids on fetal neurodevelopment during pregnancy","authors":"Xialei Li, Yue-Han Guo, Shuting Wei, Ju Chen, Yibo Wu","doi":"10.53388/life2020-0424-301","DOIUrl":"https://doi.org/10.53388/life2020-0424-301","url":null,"abstract":"","PeriodicalId":61869,"journal":{"name":"TMR生命研究","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70811758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A systematic review on the neurological manifestations of COVID-19 COVID-19神经学表现的系统综述
Pub Date : 2020-01-01 DOI: 10.53388/life2020-1014-303
T. Adewunmi, A. Modinat, Hassan Lois
{"title":"A systematic review on the neurological manifestations of COVID-19","authors":"T. Adewunmi, A. Modinat, Hassan Lois","doi":"10.53388/life2020-1014-303","DOIUrl":"https://doi.org/10.53388/life2020-1014-303","url":null,"abstract":"","PeriodicalId":61869,"journal":{"name":"TMR生命研究","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70811875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The multiple effects of hyperhomocysteinemia in patients with mild-to-moderate stroke 高同型半胱氨酸血症对轻中度脑卒中患者的多重影响
Pub Date : 2020-01-01 DOI: 10.53388/life2020-0924-102
Pu Yin, X. Gu
{"title":"The multiple effects of hyperhomocysteinemia in patients with mild-to-moderate stroke","authors":"Pu Yin, X. Gu","doi":"10.53388/life2020-0924-102","DOIUrl":"https://doi.org/10.53388/life2020-0924-102","url":null,"abstract":"","PeriodicalId":61869,"journal":{"name":"TMR生命研究","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70811958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The calm of scientific art 科学艺术的平静
Pub Date : 2020-01-01 DOI: 10.53388/life2020-1002-601
U. S.
{"title":"The calm of scientific art","authors":"U. S.","doi":"10.53388/life2020-1002-601","DOIUrl":"https://doi.org/10.53388/life2020-1002-601","url":null,"abstract":"","PeriodicalId":61869,"journal":{"name":"TMR生命研究","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70812215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do our brains really belong to us? 我们的大脑真的属于我们吗?
Pub Date : 2020-01-01 DOI: 10.53388/life2020-0425-601
Xin Wang
{"title":"Do our brains really belong to us?","authors":"Xin Wang","doi":"10.53388/life2020-0425-601","DOIUrl":"https://doi.org/10.53388/life2020-0425-601","url":null,"abstract":"","PeriodicalId":61869,"journal":{"name":"TMR生命研究","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70811652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
TMR生命研究
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1